Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 3
FRAmework-01: A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) Versus Chemotherapy or Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer, and Sofetabart Mipitecan Plus Bevacizumab Versus Platinum-Based Chemotherapy Plus Bevacizumab in Platinum-Sensitive Ovarian Cancer.
This is a clinical study that has two parts. It is testing a potential new medicine called Sofetabart Mipitecan (LY4170156) for people with certain types of ov…
Ovarian NeoplasmsFallopian Tube NeoplasmsPeritoneal Neoplasms+1 more
Eli Lilly and CompanyNCT07213804
Phase 2
An Open-label, Global, Multi-Arm Study to Evaluate the Efficacy and Safety of Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers (BELLA)
This is a Phase 2, open-label, global, multi-arm study to evaluate efficacy and safety of relacorilant in combination with other treatments in patients with gy…
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms+1 more
Corcept TherapeuticsNCT06906341